Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-005-8 | CAS number: 102-09-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- Assessment based on physico-chemical properties of the compound and on toxicological data. Experimental toxicokinetic studies were not performed
- Type of information:
- other: Assessment based on physico-chemical properties of the compound and on toxicological data. Experimental toxicokinetic studies were not performed
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The toxicokinetic assessment of diphenyl carbonate is based on physico-chemical properties of the compound and on toxicological data. Experimental toxicokinetic studies were not performed.
- Principles of method if other than guideline:
- Statement on toxicokinetics
Reference
Description of key information
The following remarks on the toxicokinetics of diphenyl carbonate are based on physico-chemical properties of the compound and on toxicological data. Inhalation exposure to the vapour is expected to be negligible. Subsequent to oral ingestion, intestinal absorption is observed. Toxicological experiments did not point to a relevant dermal absorption. Diphenyl carbonate is expected to be widely distributed throughout the body. DNA-reactive metabolites of diphenyl carbonate will most probably not be generated in mammals in the course of hepatic biotransformation.
Key value for chemical safety assessment
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 25
- Absorption rate - inhalation (%):
- 100
Additional information
The following remarks on the toxicokinetics of diphenyl carbonate are based on physico-chemical properties of the compound and on toxicological data (Tegethoff, 2008). Experimental toxicokinetic studies were not performed.
Diphenyl carbonate is a solid with a very low vapour pressure under normal ambient conditions (0.014 Pa); therefore inhalation exposure to the vapour is expected to be negligible. Diphenyl carbonate (molecular mass of 214 g/mole) has a moderate to low solubility in water (13 mg/L). Its log Pow of 3.28 and its solubility in organic solvents suggest intestinal absorption subsequent to oral ingestion. This assumption is confirmed by the results of acute and repeated dose oral toxicity studies, indicating bioavailability of the compound by showing dose related toxic effects with an LD50 of 1500 mg/kg bw/day in rats after acute exposure (FitzGerald, 1990) and at doses of ≥ 427 mg/kg bw/day (LOAEL) in male rats and ≥ 219 mg/kg bw/day (LOAEL) in female rats after repeated exposure (Eiben, 2003a).
Molecular weight, log Pow and lipophilicity of diphenyl carbonate indicate that absorption through the skin after dermal exposure is likely. However, toxicological experiments did not point to a relevant dermal absorption. After dermal treatment of rats with 2000 mg/kg bw for 24 hours under occlusive conditions no signs of systemic or local toxicity were observed (Krötlinger, 1999), whereas this dose led to marked toxicity via the oral route (FitzGerald, 1990).
Diphenyl carbonate is expected to be widely distributed throughout the body. Signs of toxicity became obvious in the liver, adrenals and ovaries of rats after repeated oral exposure (Eiben, 2003a; Eiben, 2003b). Clonic convulsions after oral administration of high diphenyl carbonate doses indicate access to the central nervous system (FitzGerald, 1990 and Eiben, 2002). Based on the results of several in vitro genotoxicity tests (Ames-Tests: Timm, 1989; Loveday, 1991; gene mutation assay: Wollny, 1996; chromosomal aberration assay: Czich, 1996, all performed with and without metabolic activation) it is concluded that DNA-reactive metabolites of diphenyl carbonate will most probably not be generated in mammals in the course of hepatic biotransformation. This conclusion is confirmed in vivo by negative results obtained in two mouse micronucleus tests (Völkner, 2000; Herbold, 1999) and in the in vivo UDS test on rat liver (San, 2002).
In the absence of quantitative experimental data, inhalation absrobtion is set to the default value of 100%, oral absorption to 50%, and dermal absorption to 25% in line with current EFSA guidance on the dermal of absorption of materials in the absence of data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.